Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1997-06-24
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 81, 514412, 548251, 548252, 548414, 548452, C07D20902, C07D40312, A61K 3140, A61K 3141
Patent
active
056417985
ABSTRACT:
This invention provides novel bicyclic compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides intermediates useful in the synthesis of excitatory amino acid antagonists.
REFERENCES:
patent: 4691022 (1987-09-01), Henning et al.
patent: 4999370 (1991-03-01), Ruger et al.
Zimmerman, D.M. et al, Trends in Medicinal Chemistry '90, Oxford (1991), pp. 145-151.
Watkins, J.C., Can. J. Physiol. Pharmacol., (1991), vol. 69, pp. 1064-1075.
Rogawski, M.A., Drugs, (1992) vol. 44, No. 3, pp. 279-292.
Ornstein, P.L. et al., J. Med. Chem., (1991), vol. 34, pp. 90-97.
Eli Lilly and Company
Hay Martin A.
Springer David B.
LandOfFree
Bicyclic compounds and their use as excitatory amino acid recept does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic compounds and their use as excitatory amino acid recept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compounds and their use as excitatory amino acid recept will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-149504